Infectious Diseases News and Research

RSS

One Health approach for emergent and resurgent infectious diseases

A recent editorial published in The Lancet Microbe underscored the ‘One Health’ policy for surveilling emergent infectious diseases.

29 Jul 2022

New breakthrough shows antimicrobial resistance is more evolved than previously recognized

Researchers have discovered a significant and previously unknown mechanism that many bacteria use to resist antibiotics.

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

Everything you need to know about Paxlovid — especially, should you take it?

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid.

28 Jul 2022

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

In our latest interview, News-Medical speaks to Simon Parker, an infectious disease specialist, about hepatitis C diagnostics and testing, as well as why the global fight against hepatitis cannot wait.

28 Jul 2022

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

Researchers found significant seroreversion of total anti-nucleocapsid immunoglobulin.

28 Jul 2022

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger immune response, and suggesting a dose up the nose has an advantage over a shot.

27 Jul 2022

Innovative technology reveals new insights into cellular reservoirs of HIV

In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases' (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

27 Jul 2022

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

The intranasal delivery of amph-protein vaccines is a potential approach to elicit a mucosal immune response against many infectious diseases.

26 Jul 2022

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

In a pair of related studies, published July 26, 2022 online via First Release in Science, researchers at University of California San Diego, with colleagues on four continents, show that the origin of the COVID-19 pandemic in 2019 was at the Huanan Seafood Wholesale Market in Wuhan, China, and resulted from at least two instances of the SARS-CoV-2 virus jumping from live animal hosts to humans working or shopping there.

26 Jul 2022

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

26 Jul 2022

New method uses drones to quickly deliver at-home COVID-19 diagnostic tests

Researchers at the Texas A&M University School of Public Health have developed a new COVID-19 test distribution method that uses drones to quickly deliver at-home diagnostic tests to individuals who suspect they have COVID-19.

25 Jul 2022

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Wake Forest Institute for Regenerative Medicine (WFIRM) researchers are investigating a drug used to treat neuromuscular weakness as a potential treatment for botulism, a rare but serious disease.

25 Jul 2022

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

In what is believed to be a first, a research team led by Duke Health has demonstrated a way to use CRISPR technology to successfully prevent and treat COVID infections.

25 Jul 2022

New RT-PCR platform gives results faster than other COVID-19 tests on the market

For more than 30 years, polymerase chain reaction (PCR) has been the gold standard in molecular diagnostic testing, detecting genetic material, such as those from a virus or from human DNA.

25 Jul 2022

Study provides the crucial antigenic map of SARS-CoV-2 variants of concern

Twenty different COVID-19 variants were effectively identified and neutralized after a third booster, according to the new study for which the University of Surrey provided the crucial antigenic map of variants of concern.

25 Jul 2022

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

For a glimpse into the future of SARS-CoV-2 immunity, scientists at La Jolla Institute for Immunology (LJI) are investigating how the immune system builds its defenses against common cold coronaviruses (CCCs).

21 Jul 2022

New AI software can create proteins that may be useful as vaccines, cancer treatments

Scientists have developed artificial intelligence software that can create proteins that may be useful as vaccines, cancer treatments, or even tools for pulling carbon pollution out of the air.

21 Jul 2022

A different approach to build a more durable, broadly effective COVID-19 vaccine

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

21 Jul 2022

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

The Centers for Disease Control and Prevention (CDC) has recommended that Novavax's COVID-19 vaccine be used as another primary series option for adults in the United States ages 18 years and older.

20 Jul 2022

Infectious Diseases News and Research

One Health approach for emergent and resurgent infectious diseases

New breakthrough shows antimicrobial resistance is more evolved than previously recognized

Moderna COVID vaccine is more effective in older and sicker veterans over time

Everything you need to know about Paxlovid — especially, should you take it?

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

The kinetics of SARS-CoV-2 nucleocapsid antibodies up to 21 months after infection

Incorporating a coronavirus antigen into MMR vaccine to produce COVID-19 immunity in kids

Innovative technology reveals new insights into cellular reservoirs of HIV

Nasal spray highly effective against HIV and SARS-CoV-2 in animal models

Researchers pinpoint multiple zoonotic origins of SARS-CoV-2

SLU and industry partners report the first effective drug to treat rare, genetic liver disease

New method uses drones to quickly deliver at-home COVID-19 diagnostic tests

Researchers investigate a drug used for neuromuscular weakness as potential treatment for botulism

Using CRISPR technology to successfully prevent and treat SARS-CoV-2 infections

New RT-PCR platform gives results faster than other COVID-19 tests on the market

Study provides the crucial antigenic map of SARS-CoV-2 variants of concern

LJI study about common cold coronaviruses may offer clues to how immunity can build up against SARS-CoV-2

New AI software can create proteins that may be useful as vaccines, cancer treatments

A different approach to build a more durable, broadly effective COVID-19 vaccine

Novavax COVID-19 vaccine now available in the U.S. to protect against severe disease

eBook: Advancing infectious disease vaccine development eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News